Posts Tagged ‘Radiation therapy’
In a groundbreaking new study just published in the peer reviewed journalStem Cells, researchers at UCLA’s Jonsson Comprehensive Cancer Center Department of Oncology found that, despite killing half of all tumor cells per treatment, radiation treatments on breast cancer transforms other cancer cells into cancer stem cells which are vastly more treatment-resistant than normal cancer cells. The new study is yet another blow to the failed and favored mainstream treatment paradigm of trying to cut out, poison out or burn out cancer symptoms (tumors) instead of actually curing cancer.
Senior study author Dr. Frank Pajonk, associate professor of radiation oncology at the Jonsson Center, reported that induced breast cancer stem cells (iBCSC) “were generated by radiation-induced activation of the same cellular pathways used to reprogram normal cells into induced pluripotent stem cells (iPS) in regenerative medicine.” Pjonk, who is also a scientist with the Eli and Edythe Broad Center of Regenerative Medicine at UCLA, added “It was remarkable that these breast cancers used the same reprogramming pathways to fight back against the radiation treatment.”
In the new study, Pajonk and his team irradiated normal non-stem cell cancer cells and placed them into mice. Through a unique imaging system, the researchers observed the cells differentiate into iBCSC in response to radiation treatments. Pjonk reported that the newly generated cells were remarkably similar to non-irradiated breast cancer stem cells. The team of researchers also found that the radiation-induced stem cells had a more than 30-fold increased ability to form tumors compared with non-irradiated breast cancer cells.
Despite mounting evidence, mainstream medicine clings to surgery, chemo and radiation and ignores natural solutions
Despite all the billions of dollars spent on cancer, the 40 year “war on cancer” has been a losing one by any honest evaluation. One hundred years ago, anywhere from 1 in 50 to perhaps 1 in 100 people could be expected to develop cancer. Now it is estimated that 1 in every 2 men and 1 in every 3 women will be diagnosed with cancer in their lifetimes. Despite more people around the world developing cancer and dying from cancer every year, mainstream medicine continues to cling to failed treatments which more often than not fail to eliminate the cancer and help cancer spread and return more aggressively than ever. Notably, two of the three major mainstream cancer treatments – radiation and chemo – are themselves highly carcinogenic.
One might think that the new study provided ample reasons to rethink using radiation. However, the study authors looked at the results as an opportunity to continue and enhance the use of radiation by finding ways to control the cell differentiation. What the scientists failed to note is that natural alternatives have already been found which prevent the development of cancer stem cells.
As just one example, Natural News reported in May 2010 that a University of Michigan study had found a compound in broccoli and broccoli sprouts which had the ability to target cancer stem cells. See:
The researchers failed to note how cancer cells fought against unnatural treatments. They also failed to take into account the mounting evidence that the best way to beat cancer as well as avoid it is to build and enhance our natural first line of defense – our immune system.
The safest and most effective way to enhance the natural immune system and fight cancer in general is by working with nature. It is also by far the least expensive way, and therein likely lies the rub. You can’t patent and profit from nature like you can with mainstream drugs and treatments.
Note: Neither NaturalNews nor this author condone the inhumane use of animals in medical studies.
Other sources included:
About the author:
Tony Isaacs, is a natural health author, advocate and researcher who hostsThe Best Years in Lifewebsite for those who wish to avoid prescription drugs and mainstream managed illness and live longer, healthier and happier lives naturally. Mr. Isaacs is the author of books and articles about natural health, longevity and beating cancer including “Cancer’s Natural Enemy” and is working on a major book project due to be published later this year. He is also a contributing author for the worldwide advocacy group “S.A N.E.Vax. Inc” which endeavors to uncover the truth about HPV vaccine dangers.
Mr. Isaacs is currently residing in scenic East Texas and frequently commutes to the even more scenic Texas hill country near Austin and San Antonio to give lectures and health seminars. He also hosts the CureZone “Ask Tony Isaacs – featuring Luella May” forum as well as the Yahoo Health Group “Oleander Soup” and he serves as a consultant to the “Utopia Silver Supplement Company“.
New research published in the Journal of the National Cancer Institute this month shows that targeted radiation for breast cancer has been widely overused. The research uses new criteria established in 2009 by the American Society for Radiation Oncology (ASTRO) for the use of brachytherapy (targeted irradiation for breast cancer). It compares that new criteria with patient records from the past several years, showing that 2/3 of those receiving brachytherapy probably should not have.
Using records from 138,815 U.S. women who’d received brachytherapy from 2000 to 2007, the study shows that most of them do not fit into the currently recommended criteria for the therapy. This would likely account for some higher recurrence rates amongst the women.
The study compared women who received targeted radiation and those who received the more common whole breast irradiation (WBI). It found that 29.6% of the women receiving brachytherapy would have been classified as “cautionary” (not likely to benefit) and 36.2% would have been classified as “unsuitable” under current ASTRO criteria.
The study briefly discussed cancer return rates (versus recurrence in WBI), but admits that this data would be too preliminary given the specific scope of the study itself.
Targeted irradiation is more convenient for women, since it requires only about a week of therapy instead of a full month, but is designed for very specific situations that only about 7-10% of breast cancer patients fall into. Its use, the study found, varies greatly by geographic region, by rural versus urban (urban is more likely), and by racial demographic (whites are more likely to receive it), but not necessarily by means or income (Medicare covers it).
Findings from another study published this year show that women who receive brachytherapy at twice as likely to eventually have a mastectomy than those who receive WBI.